Continuing Education Course #2: Current Understanding of Hemostasis

Advances in Antiplatelet Therapy for Stroke Prevention: the New P2Y12 antagonists

(2010) A. Giossi et al.   CURRENT DRUG TARGETS

Factor V Is an Anticoagulant Cofactor for Activated Protein C during Inactivation of Factor Va

(2010) Thomas J. Cramer et al.   pathophysiology of haemostasis and thrombosis

How I treat von Willebrand disease

(2009) F. Rodeghiero et al.   BLOOD

Antiplatelet therapy in percutaneous coronary intervention: A critical review of the 2007 AHA/ACC/SCAI guidelines and beyond

(2009) Marc Cohen   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke

(2009) Ralph Weber et al.   EXPERT OPINION ON PHARMACOTHERAPY

Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance

(2009) V. TERRAUBE et al.   HAEMOPHILIA

Cell Adhesion Mechanisms in Platelets

(2008) David Varga-Szabo et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Venous and arterial thrombosis: Different sides of the same coin?

(2008) Massimo Franchini et al.   European Journal of Internal Medicine

Back to the future: a recent history of haemophilia treatment

(2008) P. M. MANNUCCI   HAEMOPHILIA